Literature DB >> 21639848

Free radical reaction products and antioxidant capacity in beating heart coronary artery surgery compared to conventional bypass.

A Gonenc1, A Hacişevki, H R Griffiths, M Torun, B Bakkaloglu, B Simsek.   

Abstract

Oxygen-derived free radicals are important agents of tissue injury during ischemia and reperfusion. The aim of this study was to investigate changes in protein and lipid oxidation and antioxidant status in beating heart coronary artery surgery and conventional bypass and to compare oxidative stress parameters between the two bypass methods. Serum lipid hydroperoxide, nitric oxide, protein carbonyl, nitrotyrosine, vitamin E, and β-carotene levels and total antioxidant capacity were measured in blood of 30 patients undergoing beating heart coronary artery surgery (OPCAB, off-pump coronary artery bypass grafting) and 12 patients undergoing conventional bypass (CABG, on-pump coronary artery bypass grafting). In the OPCAB group, nitric oxide and nitrotyrosine levels decreased after reperfusion. Similarly, β-carotene level and total antioxidant capacity also decreased after anesthesia and reperfusion. In the CABG group, nitric oxide and nitrotyrosine levels decreased after ischemia and reperfusion. However, protein carbonyl levels elevated after ischemia and reperfusion. Vitamin E, β-carotene, and total antioxidant capacity decreased after ischemia and reperfusion. Significantly decreased nitration and impaired antioxidant status were seen after reperfusion in both groups. Moreover, elevated protein carbonyls were found in the CABG group. The off-pump procedure is associated with lower degree of oxidative stress than on-pump coronary surgery.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21639848     DOI: 10.1134/S0006297911060083

Source DB:  PubMed          Journal:  Biochemistry (Mosc)        ISSN: 0006-2979            Impact factor:   2.487


  7 in total

1.  A preliminary study about the effects of warm priming solution on oxidative stress and postoperative atrial fibrillation in open heart surgery.

Authors:  Mustafa Buyukates; Serefden Acikgoz; Erol Aktunc; Ozer Kandemir; Sait Mesut Dogan; Mustafa Aydin
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

2.  Effect of citrate phosphate dextrose solution on reperfusion injury in coronary artery bypass surgical patients undergoing cardiopulmonary bypass.

Authors:  Alireza Yaghoubi; Saeid Danaee; Shahin Imani; Mohammadali Sheikhalizadeh; Morteza Ghojazadeh
Journal:  J Cardiovasc Thorac Res       Date:  2011-12-20

3.  Changes of sFas and sFasL, oxidative stress markers in serum and follicular fluid of patients undergoing IVF.

Authors:  Aslıhan Pekel; Aymelek Gönenç; Nilgün Öztürk Turhan; Hasan Kafalı
Journal:  J Assist Reprod Genet       Date:  2014-12-09       Impact factor: 3.412

4.  Circulating miR-126 and miR-499 reflect progression of cardiovascular disease; correlations with uric acid and ejection fraction.

Authors:  Masoud Khanaghaei; Fereshtah Tourkianvalashani; Seyedhossein Hekmatimoghaddam; Nasrin Ghasemi; Mahdi Rahaie; Vahid Khorramshahi; Akhtar Sheikhpour; Zahra Heydari; Fatemeh Pourrajab
Journal:  Heart Int       Date:  2016-04-26

5.  The Effect of On-Pump and Off-Pump Bypass Operations on Oxidative Damage and Antioxidant Parameters.

Authors:  Ayse Dogan; Fevzi Sarper Turker
Journal:  Oxid Med Cell Longev       Date:  2017-12-17       Impact factor: 6.543

6.  Does high thoracic epidural analgesia with levobupivacaine preserve myocardium? A prospective randomized study.

Authors:  Serife Gokbulut Bektas; Sema Turan; Umit Karadeniz; Burcin Ozturk; Soner Yavas; Dilan Biricik; Gul Sevim Saydam; Ozcan Erdemli
Journal:  Biomed Res Int       Date:  2015-03-31       Impact factor: 3.411

7.  Circulating microRNAs indicate cardioprotection by sevoflurane inhalation in patients undergoing off-pump coronary artery bypass surgery.

Authors:  Xiao Liu; Xiaopeng Liu; Ruike Wang; Hui Luo; Gang Qin; L U Wang; Zhi Ye; Qulian Guo; E Wang
Journal:  Exp Ther Med       Date:  2016-03-24       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.